Labs / CDMO: development & manufacturing

Vicero Bio
Cambridge, MA, United States · vicerobio.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Vicero Bio develops VINCOBODY-based immunotherapy programs for cancer. It works on multi-specific VHH therapeutics and multi-payload ADCs, with a lead program aimed at colorectal cancer and partnerships for R&D, clinical development, and platform access.
They take quote requests by email.
What they offer
VINCOBODY platform development
Develops a proprietary VINCOBODY platform for building multi-specific cancer therapies.
Multi-specific immunotherapy programs
Advances multi-target immuno-oncology therapeutics designed to combine multiple immune pathways on one scaffold.
ADC program development
Develops multi-payload antibody drug conjugate programs using the VINCOBODY platform.
R&D alliances
Partners with organizations to explore novel targets and combinations.
Clinical collaborations
Works with collaborators to accelerate development of high-potential programs.
Technology access partnerships
Provides access partnerships to expand the reach of the VINCOBODY platform.
What they work on
- Modalities
- Small molecule, Antibody, Bispecific, ADC, Cell therapy
- Species and models
- E. coli
- Therapeutic areas
- cancer, oncology, colorectal cancer, solid tumors
Similar labs. Bambusa Therapeutics, ORF Biologics, AGC Biologics, Evotec
Found in a contract services directory. Listing built from vicerobio.com. Work here? Claim this listing.